Allstate Q3 Results Due as Stock Rallies Past Analyst Targets

Allstate reports Q3 results on November 4, having added 15% in the past month and now trading at $259.87, above the $269 consensus price target that was already trimmed aggressively through October.

The stock's position relative to analyst targets is the sharpest tension into this print. Following Q3 results on October 28, the shares rose 1.7% on the day and have continued higher, leaving them only $9 short of the consensus. That target itself is the product of heavy cutting: Goldman Sachs reduced to $250 from $280, Morgan Stanley to $240 from $265, and Citigroup to $215 from $240, all in the first two weeks of October. Wells Fargo moved against the tide, upgrading to Equal-Weight while simultaneously lowering its target to $236. The net result is a Hold consensus with most targets clustered well below where the stock is trading, a configuration that puts the burden on this print to justify the gap rather than narrow it.

The bull and bear camps converge on the same underlying question: whether Allstate's underwriting recovery has more room. Bulls point to policies-in-force growth of 2.8% monthly in personal auto, an earnings beat last quarter driven by favorable loss reserve development, and a factor rank in the 94th percentile on EPS surprise. Bears counter that a combined ratio of 89.4% still trails the company's own 95% long-term target, that competitive pressure in personal lines could erode recent pricing gains, and that two analysts maintain outright Sell ratings with targets of $215 and $221. The earnings yield factor ranks at the 86th percentile and EV/EBIT at the 89th, which provides some valuation support, though the price-to-book has expanded 0.23 points over the past month as the stock has run.

The short side carries no meaningful pressure here. Short interest is 2.4% of the float, down roughly 8% on the week, and the lending market is exceptionally loose. Availability is extremely wide, with about 168 million shares available against the roughly 6.3 million currently borrowed. Borrowing costs are barely above zero at 0.40%. Insider activity over the past 90 days has been net negative, with approximately $23.8 million in net selling, though the October transactions were predominantly option exercises and tax-withholding sales rather than discretionary open-market disposals.

The November 4 print will test whether Allstate's underlying loss trends remain favorable enough to give analysts reason to lift targets back toward the current price, or whether the stock's October rally has run ahead of what the numbers can support.